These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 4445767

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Fairley GH.
    Ser Haematol; 1973; 6(2):196-201. PubMed ID: 4784374
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK, Frei E, Gehan EA, Coltman CA, Talley R, Monto RW.
    Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Nissen NI, Stutzman L, Holland JF, Glidewell OJ.
    Arch Intern Med; 1973 Mar; 131(3):396-401. PubMed ID: 4688038
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    DeVita VT.
    Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
    [No Abstract] [Full Text] [Related]

  • 15. Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
    Frei E, Luce JK.
    JAMA; 1973 Jan 08; 223(2):166-8. PubMed ID: 4739456
    [No Abstract] [Full Text] [Related]

  • 16. [Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Andrieu JM, Casassus P, Coscas Y, Darmont J, Goubeau C, Katz M, Jacquillat C, Tricot G, Weil M.
    Bull Cancer; 1982 Jan 08; 69(4):321-9. PubMed ID: 6897520
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
    Huart M.
    Rev Prat; 1974 Oct 11; 24(45):3995-8. PubMed ID: 4216953
    [No Abstract] [Full Text] [Related]

  • 19. [Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    Babini L, Sciascia R, Baccarani M, Emiliani E, Fiacchini M, Franchini A, Lauria F, Tura S.
    Radiol Med; 1978 Feb 11; 64(2):113-8. PubMed ID: 684251
    [No Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Sacks P, Jacobs P, Gale D, Lynch SR, Bothwell TH, Stevens K.
    S Afr Med J; 1973 Jun 02; 47(21):903-7. PubMed ID: 4351107
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.